Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Zhejiang Taimei Medical Technology Co Days Payable?
Zhejiang Taimei Medical Technology CoHKSE:02576 +1.96%11 Days Payable is 128.46 as of Dec. 2025, which is 131% above its 10-year median of 55.50. GuruFocus rates HKSE:02576 with a GF Score™ of 11/100. The stock has 4 warning signs investors should review. Among 605 Healthcare Providers & Services companies, Zhejiang Taimei Medical Technology Co ranks better than 76.53% on this metric.
HKSE:02576's Days Payable is ranked better than 76.53% of 605
companies
in the Healthcare Providers & Services industry
Industry Median: 56.95
vs HKSE:02576: 128.16
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhejiang Taimei Medical Technology Co Days Payable Chart
Zhejiang Taimei Medical Technology Co Annual Data
Trend
Dec21
Dec22
Dec23
Dec24
Dec25
Days Payable
51.69
47.65
55.50
96.46
124.18
Zhejiang Taimei Medical Technology Co Semi-Annual Data
HKSE:02576 vs VEEV, BTSG, HQY: Days Payable Comparison
For the Health Information Services subindustry, Zhejiang Taimei Medical Technology Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zhejiang Taimei Medical Technology Co Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Zhejiang Taimei Medical Technology Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Zhejiang Taimei Medical Technology Co's Days Payable falls into.
Zhejiang Taimei Medical Technology Co Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhejiang Taimei Medical Technology Co (HKSE:02576) has a Days Payable of 128.46 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Zhejiang Taimei Medical Technology Co and its competitors. This is 131% above median its historical median of 55.50. Over the past decade, Zhejiang Taimei Medical Technology Co's Days Payable has ranged from 47.65 to 128.16. According to the industry distribution chart, Zhejiang Taimei Medical Technology Co ranks #142 out of 605 companies in the Healthcare Providers & Services industry, placing it in the top 23.5%.
Is Zhejiang Taimei Medical Technology Co's Days Payable too high?
Zhejiang Taimei Medical Technology Co's current Days Payable of 128.46 is 131% above median its 10-year median of 55.50. Over the past 10 years, this metric has ranged from a low of 47.65 to a high of 128.16. The Healthcare Providers & Services industry median Days Payable is 56.95. Zhejiang Taimei Medical Technology Co's value of 128.46 is 125.6% above this industry median. Based on the distribution chart, Zhejiang Taimei Medical Technology Co ranks #142 out of 605 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Zhejiang Taimei Medical Technology Co has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Zhejiang Taimei Medical Technology Co's Days Payable compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Zhejiang Taimei Medical Technology Co ranks #142 out of 605 companies for Days Payable. This places Zhejiang Taimei Medical Technology Co in the top 24% of its industry — outperforming the majority of peers. The industry median Days Payable is 56.95. Zhejiang Taimei Medical Technology Co's value of 128.46 is 125.6% above this benchmark. Historically, Zhejiang Taimei Medical Technology Co's own Days Payable has ranged from 47.65 to 128.16 over the past decade. While the company's 10-year median is 55.50 vs. the industry median of 56.95, Zhejiang Taimei Medical Technology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 56.95, based on 605 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zhejiang Taimei Medical Technology Co's current Days Payable of 128.46 is 125.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Zhejiang Taimei Medical Technology Co and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 56.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zhejiang Taimei Medical Technology Co's current Days Payable is 128.46, which is 131% above median its own 10-year median of 55.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhejiang Taimei Medical Technology Co stock overvalued right now?
Zhejiang Taimei Medical Technology Co (HKSE:02576) has a current Days Payable of 128.46. The current Days Payable is 128.46, which is 131% above median its 10-year median of 55.50 and 125.6% above the Healthcare Providers & Services industry median of 56.95. Zhejiang Taimei Medical Technology Co's overall GF Score™ is 11/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Zhejiang Taimei Medical Technology Co (HKSE:02576), the current Days Payable is 128.46 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Zhejiang Taimei Medical Technology Co Ltd is a digital solution provider focused on the pharmaceutical and medical device industry in China. It designs and delivers industry-specific software and digital services that facilitate research and development (R&D) and the commercialization of pharmaceuticals and medical devices. The software it offers is cloud-based, allowing users to access it from various devices at any time over the internet, without the need for software installation and maintenance on their devices. It has a geographical presence in Mainland China, the United States, Singapore, Korea, and Others.
11GF Score
Get the complete analysis for HKSE:02576
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02576 has been successfully added to your 
